Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9587 | 1074 | 40.4 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1258 | 8423 | PHAGE DISPLAY//CATALYTIC ANTIBODIES//CATALYTIC ANTIBODY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CANONICAL STRUCTURES | Author keyword | 17 | 62% | 2% | 18 |
2 | CDR CONFORMATION | Author keyword | 8 | 100% | 0% | 5 |
3 | ANTIBODY STRUCTURE | Author keyword | 7 | 29% | 2% | 21 |
4 | ANTIBODY ANTIGEN COMPLEX | Author keyword | 7 | 46% | 1% | 11 |
5 | ANTIBODY MODELING | Author keyword | 5 | 45% | 1% | 9 |
6 | HYPERVARIABLE LOOPS | Author keyword | 5 | 55% | 1% | 6 |
7 | ANTIDIGOXIN ANTIBODY | Author keyword | 4 | 75% | 0% | 3 |
8 | COMPLEMENTARY DETERMINING REGIONS | Author keyword | 4 | 75% | 0% | 3 |
9 | FAB COMPLEX | Author keyword | 4 | 75% | 0% | 3 |
10 | TAG72 ANTIGEN | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CANONICAL STRUCTURES | 17 | 62% | 2% | 18 | Search CANONICAL+STRUCTURES | Search CANONICAL+STRUCTURES |
2 | CDR CONFORMATION | 8 | 100% | 0% | 5 | Search CDR+CONFORMATION | Search CDR+CONFORMATION |
3 | ANTIBODY STRUCTURE | 7 | 29% | 2% | 21 | Search ANTIBODY+STRUCTURE | Search ANTIBODY+STRUCTURE |
4 | ANTIBODY ANTIGEN COMPLEX | 7 | 46% | 1% | 11 | Search ANTIBODY+ANTIGEN+COMPLEX | Search ANTIBODY+ANTIGEN+COMPLEX |
5 | ANTIBODY MODELING | 5 | 45% | 1% | 9 | Search ANTIBODY+MODELING | Search ANTIBODY+MODELING |
6 | HYPERVARIABLE LOOPS | 5 | 55% | 1% | 6 | Search HYPERVARIABLE+LOOPS | Search HYPERVARIABLE+LOOPS |
7 | ANTIDIGOXIN ANTIBODY | 4 | 75% | 0% | 3 | Search ANTIDIGOXIN+ANTIBODY | Search ANTIDIGOXIN+ANTIBODY |
8 | COMPLEMENTARY DETERMINING REGIONS | 4 | 75% | 0% | 3 | Search COMPLEMENTARY+DETERMINING+REGIONS | Search COMPLEMENTARY+DETERMINING+REGIONS |
9 | FAB COMPLEX | 4 | 75% | 0% | 3 | Search FAB+COMPLEX | Search FAB+COMPLEX |
10 | TAG72 ANTIGEN | 4 | 75% | 0% | 3 | Search TAG72+ANTIGEN | Search TAG72+ANTIGEN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPERVARIABLE REGIONS | 61 | 33% | 14% | 154 |
2 | FAB COMPLEX | 51 | 69% | 4% | 44 |
3 | CANONICAL STRUCTURES | 39 | 46% | 6% | 63 |
4 | IDIOTYPE FAMILY | 23 | 86% | 1% | 12 |
5 | D13 | 15 | 82% | 1% | 9 |
6 | COMBINING SITES | 15 | 34% | 3% | 36 |
7 | ANTILYSOZYME ANTIBODY | 15 | 88% | 1% | 7 |
8 | FAB FRAGMENT | 14 | 21% | 6% | 60 |
9 | ANTILYSOZYME MONOCLONAL ANTIBODY | 13 | 80% | 1% | 8 |
10 | LIGHT CHAIN DIMER | 13 | 62% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Interactions of protein antigens with antibodies | 1996 | 386 | 57 | 63% |
ANATOMY OF THE ANTIBODY MOLECULE | 1994 | 578 | 125 | 56% |
Computer-aided antibody design | 2012 | 38 | 193 | 33% |
STRUCTURAL FEATURES OF THE REACTIONS - BETWEEN ANTIBODIES AND PROTEIN ANTIGENS | 1995 | 146 | 52 | 54% |
X-ray crystallography of antibodies | 1996 | 117 | 111 | 63% |
ANTIBODY-ANTIGEN COMPLEXES | 1990 | 652 | 89 | 40% |
Molecular recognition in anti body-antigen complexes | 2003 | 128 | 117 | 45% |
The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab5G9 and TF center dot 5G9 complex | 1998 | 78 | 86 | 43% |
LENGTH DISTRIBUTION OF CDRH3 IN ANTIBODIES | 1993 | 208 | 24 | 42% |
Antibody informatics for drug discovery | 2014 | 2 | 77 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOMOLEC ENGN 343 ROYAL PARADE | 1 | 50% | 0.2% | 2 |
2 | HGEBIET PROT MODELLING | 1 | 100% | 0.2% | 2 |
3 | CRYSTALLOG PROGRAM | 1 | 13% | 0.8% | 9 |
4 | RD IMMUNOESSAIS | 1 | 40% | 0.2% | 2 |
5 | STRUCT IMMUNOL | 1 | 20% | 0.4% | 4 |
6 | BABRAHAM IMMUNOL STRUCT STUDIES | 1 | 50% | 0.1% | 1 |
7 | CLIN NEONATOL NEUROPEDIAT | 1 | 50% | 0.1% | 1 |
8 | IMMUNOL STRUCT STUDIES | 1 | 50% | 0.1% | 1 |
9 | VIRTUAL BIOMOL STRUCT | 1 | 50% | 0.1% | 1 |
10 | SURG AUSTIN HLTH | 0 | 11% | 0.4% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196951 | SCFV//SINGLE CHAIN FV//PHAGE DISPLAY |
2 | 0.0000185792 | PREDETERMINED SPECIFICITY//SYNTHETIC ANTIGENIC SITE//B CELL EPITOPE PREDICTION |
3 | 0.0000183706 | SORBIN//NONCOMPETITIVE IMMUNOASSAY//PHAGE ANTI IMMUNOCOMPLEX ASSAY |
4 | 0.0000178322 | LOOP PREDICTION//LOOP MODELING//STEPWISE FOLDING |
5 | 0.0000128194 | IG ALLOTYPE//UNITE IMMUNOPHYSIOL MOL//DEXTRAN B512 |
6 | 0.0000120613 | CATALYTIC ANTIBODY//CATALYTIC ANTIBODIES//ABZYMES |
7 | 0.0000113464 | SINGLE DOMAIN ANTIBODY//NANOBODY//VHH |
8 | 0.0000106742 | IMGT//UPR CNRS 1142//CNRSUPR 1142 |
9 | 0.0000101308 | WAKANYAKU ORIENTAL MED 2630 SUGITANI//// |
10 | 0.0000084111 | IMMUNOLOGICAL SIGNAL//BIOINFORMAT TELEMED//INTERDISCIPLINARY MODELING |